BeyondSpring Inc.

NASDAQ:BYSI

Biotechnology

Healthcare
$1.25 +1.58%

+$0.03 today

Market cap
$51.40M
Beta
0.42
P/E (TTM)
-8.7
EPS (TTM)
-$0.19
52W Low $1.18High $3.28

Volume 0.01M

Average 0.02M

BYSI Total Non-current Liabilities

All obligations due after more than one year.

BeyondSpring Inc.NASDAQ: BYSI

Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total non-current liabilities broadly unchanged from a year ago

Total non-current liabilities stood at $36.39M at the end of Q1 FY2026, down 1.9% from a year earlier and up 0.1% from the prior quarter. Over 3 fiscal years it compounded at -4.6% a year.

Context

  • Total non-current liabilities amounted to 197.7% of total assets at the end of Q1 FY2026, up 97.7 pp from a year earlier.
  • Total non-current liabilities increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -1.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$36.39M+0.1% QoQ
Last fiscal yearDec 2025
$36.35M-3.3% YoY
Year agoMar 2025
$37.11M-1.9% since
Total Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.9%——
1 year-3.3%——
3-year CAGR-4.6%——
5-year CAGR——
10-year CAGR——

Total Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
36.35M USD
Year-over-year change
-3.3%
4-year CAGR
-5.5%

Total Non-current Liabilities vs competitors

How BYSI compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -1.9% is the 4th highest of 8, against a peer median of -4.2%.
  • Total non-current liabilities amounts to 197.7% of total assets for BYSI, versus a peer median of 26.5%.
BYSI Competitors
Total Non-current Liabilities for BYSI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GUTSFractyl Health, Inc. Common StockMar 2026$62.6M USD+8.2%-32.6%63.0%
DTILPrecision BioSciences, Inc.Mar 2026$60.04M USD-4.2%-23.3%41.7%
CAMPCAMP4 Therapeutics CorporationMar 2026$57.93M USD+1117.0%—54.9%
BYSIBeyondSpring Inc.Mar 2026$36.39M USD-1.9%-4.6%197.7%
BMEABiomea Fusion, Inc.Mar 2026$18.37M USD+182.6%+120.7%39.6%
ATYRaTyr Pharma, Inc.Mar 2026$10.21M USD-12.7%+3.3%12.8%
ALXOALX Oncology Holdings Inc.Mar 2026$6.8M USD-50.9%-16.7%3.8%
HYFTMindWalk Holdings Corp.Jan 2026CA$3.12M CAD-72.8%+9.2%13.5%
UNCYUnicycive Therapeutics, Inc.Mar 2026$217K USD——0.3%
Peer median (excluding BYSI) —-4.2%-6.7%26.5%

Competitors are the stored peer set for BYSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents41.63M34.4M15.34M2.92M7.79M
Short-term Investments30.74M2.87M004.78M
Net Receivables00000
Inventory00000
Other Current Assets1.02M763K2.79M25.42M8.09M
Total Current Assets75.12M38.52M18.42M28.58M20.88M
Property, Plant & Equipment (Net)4.95M7.35M1.05M752K471K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.58M347K5.34M4.99M4.58M
Total Non-current Assets6.53M7.7M6.39M5.74M5.05M
Total Assets81.65M46.22M24.81M34.32M25.93M
Account Payables1.66M1.08M561K295K363K
Short-term Debt1.57M0258K00
Tax Payables4M32K16K1K0
Deferred Revenue1.37M1.35M1.75M27.4M0
Other Current Liabilities6.17M1.45M4.4M(17.58M)11.71M
Total Current Liabilities15.16M7.35M7.96M11.01M13.58M
Long-term Debt00000
Deferred Tax Liabilities5.45M0000
Deferred Revenue (Non-current)37.94M34.22M28.17M27.4M28.6M
Other Non-current Liabilities709K3.66M11.55M9.88M7.75M
Total Non-current Liabilities45.57M41.88M40.31M37.59M36.35M
Total Liabilities60.73M49.23M48.27M48.6M49.92M
Common Stock4K4K4K4K4K
Retained Earnings(342M)(375.28M)(396.3M)(407.43M)(408.43M)
Accumulated OCI(523K)436K894K1.34M602K
Other Stockholders Equity00000
Minority Interest(5.76M)2.97M3.34M18.62M8.17M
Total Equity20.92M(3.01M)(23.46M)(14.29M)(23.99M)
Total Debt3.58M4.96M847K589K320K
Net Debt(38.05M)(29.44M)(14.49M)(2.33M)(7.47M)

BeyondSpring Inc.

NASDAQ:BYSI

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.